Showing results (1621-1630 of 1,731) with videos related to

Sort By:
Pageof 174
Iscience|February 9, 2026
Leveraging health records to identify diagnoses associated with recurrent pregnancy loss across two medical centersJacquelyn Roger, Feng Xie, Jean M Costello, et al.
Oncogene|August 21, 2007
BRE is an antiapoptotic protein in vivo and overexpressed in human hepatocellular carcinomaB C-L Chan, A K-K Ching, K-F To, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 16, 2021
Beyond Teenage and Young Adult Cancer Care: Care Experiences of Patients Aged 25-39 Years Old in the UK National Health ServiceE Lidington, A S Darlington, C Vlooswijk, et al.
Stroke|September 27, 2021
Mendelian Randomization Focused Analysis of Vitamin D on the Secondary Prevention of Ischemic StrokeYap-Hang Chan, C Mary Schooling, Jie Zhao, et al.
Human Genetics|April 3, 2010
Fine mapping of the 9q31 Hirschsprung's disease locusC S Tang, Y Sribudiani, X P Miao, et al.
Nature|March 4, 2026
Precancerous niche remodelling dictates nascent tumour persistenceG Skrupskelyte, J E Rojo Arias, H Ajith, et al.
Acta Medica Philippina|November 1, 2024
Adherence of Physicians to Local Guideline Recommendations among Patients with COVID-19 in Two Tertiary Public Hospitals in Metro Manila, Philippines: A Rapid Assessment StudyAnton G Elepaño, Cynthia P Cordero, Lia M Palileo-Villanueva, et al.
Genes & Nutrition|January 30, 2022
Mendelian randomization analysis of vitamin D in the secondary prevention of hypertensive-diabetic subjects: role of facilitating blood pressure controlYap-Hang Chan, C Mary Schooling, Jie V Zhao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 14, 2016
Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapyM Moore, S Gill, T Asmis, et al.
Blood|December 21, 2018
Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphomaChristian Grommes, Sarah S Tang, Julia Wolfe, et al.
Pageof 174